1. Home
  2. ANIP vs VIAV Comparison

ANIP vs VIAV Comparison

Compare ANIP & VIAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • VIAV
  • Stock Information
  • Founded
  • ANIP 2001
  • VIAV 1923
  • Country
  • ANIP United States
  • VIAV United States
  • Employees
  • ANIP N/A
  • VIAV N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • VIAV Semiconductors
  • Sector
  • ANIP Health Care
  • VIAV Technology
  • Exchange
  • ANIP Nasdaq
  • VIAV Nasdaq
  • Market Cap
  • ANIP 2.0B
  • VIAV 2.3B
  • IPO Year
  • ANIP N/A
  • VIAV 1993
  • Fundamental
  • Price
  • ANIP $90.08
  • VIAV $10.66
  • Analyst Decision
  • ANIP Strong Buy
  • VIAV Buy
  • Analyst Count
  • ANIP 9
  • VIAV 8
  • Target Price
  • ANIP $82.89
  • VIAV $13.10
  • AVG Volume (30 Days)
  • ANIP 696.2K
  • VIAV 3.0M
  • Earning Date
  • ANIP 08-08-2025
  • VIAV 08-07-2025
  • Dividend Yield
  • ANIP N/A
  • VIAV N/A
  • EPS Growth
  • ANIP N/A
  • VIAV N/A
  • EPS
  • ANIP N/A
  • VIAV 0.15
  • Revenue
  • ANIP $747,399,000.00
  • VIAV $1,084,300,000.00
  • Revenue This Year
  • ANIP $31.40
  • VIAV $8.83
  • Revenue Next Year
  • ANIP $7.38
  • VIAV $4.75
  • P/E Ratio
  • ANIP N/A
  • VIAV $70.80
  • Revenue Growth
  • ANIP 38.68
  • VIAV 8.39
  • 52 Week Low
  • ANIP $52.50
  • VIAV $7.80
  • 52 Week High
  • ANIP $91.01
  • VIAV $12.91
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 80.26
  • VIAV 57.98
  • Support Level
  • ANIP $85.44
  • VIAV $10.30
  • Resistance Level
  • ANIP $68.18
  • VIAV $10.88
  • Average True Range (ATR)
  • ANIP 3.40
  • VIAV 0.38
  • MACD
  • ANIP 1.96
  • VIAV 0.03
  • Stochastic Oscillator
  • ANIP 96.69
  • VIAV 36.11

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

Share on Social Networks: